Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("GROBECKER H")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 66

  • Page / 3

Export

Selection :

  • and

UNTERSUCHUNGEN ZUM WIRKUNGSMECHANISMUS VON HEPTAMINOL. = RECHERCHES SUR LE MECANISME D'ACTION DE L'HEPTAMINOLGROBECKER H; GROBECKER H.GROBECKER H; GROBECKER H.1976; ARZNEIMITTEL-FORSCH.; DTSCH.; DA. 1976; VOL. 26; NO 12; PP. 2167-2171; ABS. ANGL.; BIBL. 22 REF.Article

QUANTITATIVE PARAMETER DER SYMPATHO-NERVALEN UND SYMPATHO-ADRENALEN AKTIVITAET BEIM MENSCHEN. EINFLUSS VON BETA -REZEPTORENBLOCKERN. = LES PARAMETRES QUANTITATIFS DE L'ACTIVITE SYMPATHO-NEURONALE ET SYMPATHO-SURRENALE CHEZ L'HOMME. INFLUENCE DES AGENTS BLOQUANT LES BETA -RECEPTEURSPALM D; GROBECKER H.1977; ARZNEIMITTEL-FORSCH.; DTSCH.; DA. 1977; VOL. 27; NO 3A; PP. 708-713; ABS. ANGL.; BIBL. 1 P.Article

Pharmacology and clinical pharmacology of organic nitratesGROBECKER, H.European journal of clinical pharmacology. 1990, Vol 38, pp S3-S7, issn 0031-6970, Suppl. 1Article

CHANGES IN CENTRAL CATECHOLAMINERGIC NEURONS IN THE SPONTANEOUSLY (GENETIC) HYPERTENSIVE RAT.SAAVEDRA JM; GROBECKER H; AXELROD J et al.1978; CIRCUL. RES.; U.S.A.; DA. 1978; VOL. 42; NO 4; PP. 529-534; BIBL. 35 REF.Article

ADRENALINE-FORMING ENZYME IN BRAINSTEM: ELEVATION IN GENETIC AND EXPERIMENTAL HYPERTENSIONSAAVEDRA JM; GROBECKER H; AXELROD J et al.1976; SCIENCE; U.S.A.; DA. 1976; VOL. 191; NO 4226; PP. 483-484; BIBL. 15 REF.Article

BIOSYNTHETIC ENZYME ACTIVITIES AND CATECHOLAMINES IN ADRENAL GLANDS OF GENETIC AND EXPERIMENTAL HYPERTENSIVE RATSGROBECKER H; SAAVEDRA JM; WEISE VK et al.1982; CIRC. RES.; ISSN 0009-7330; USA; DA. 1982; VOL. 50; NO 5; PP. 742-746; BIBL. 34 REF.Article

CATECHOLAMINES IN THE RAPHENUCLEI OF THE RAT.SAAVEDRA JM; GROBECKER H; ZIVIN J et al.1976; BRAIN RES.; NETHERL.; DA. 1976; VOL. 114; NO 2; PP. 339-345; BIBL. 25 REF.Article

PREDICTION OF THE NON-SPECIFIC CARDIODEPRESSANT EFFECTS OF BETA -ADRENOCEPTOR BLOCKING AGENTS IN VITRO AND IN VIVO BY MEANS OF THE HANSCH ANALYSIS = PREVISION DES EFFETS CARDIODEPRESSEURS NON-SPECIFIQUES DES AGENTS BLOQUANTS LES BETA -ADRENOCEPTEURS IN VITRO ET IN VIVO AU MOYEN DE L'ANALYSE DE HANSCHHELLENBRECHT D; MULLER KF; GROBECKER H et al.1974; EUROP. J. PHARMACOL.; NETHERL.; DA. 1974; VOL. 29; NO 2; PP. 223-235; BIBL. 18REF.Article

EFFECT OF TYRAMINE AND GUANETHIDINE ON DOPAMINE-BETA -HYDROXYLASE ACTIVITY AND NOREPINEPHRINE CONCENTRATIONS IN VESICULAR FRACTION OF THE HEART AND PLASMA OF RATS.GROBECKER H; ROIZEN MF; KOPIN IJ et al.1977; LIFE SCI.; G.B.; DA. 1977; VOL. 20; NO 6; PP. 1009-1015; BIBL. 22 REF.Article

CORRELATION BETWEEN INCREASED DOPAMINE-BETA -HYDROXYLASE ACTIVITY AND CATECHOLAMINE CONCENTRATION IN PLASMA: DETERMINATION OF ACUTE CHANGES IN SYMPHATETIC ACTIVITY IN MAN = CORRELATION ENTRE L'ACCROISSEMENT DE L'ACTIVITE DE LA DOPAMINE-BETA -HYDROXYLASE ET LA CONCENTRATION DE CATECHOLAMINE DANS LE PLASMA: DETERMINATION ET MODIFICATIONS AIGUES DE L'ACTIVITE SYMPATHIQUE CHEZ L'HOMMEPLANZ G; WIETHOLD G; APPEL D et al.1975; EUROP. J. CLIN. PHARMACOL.; GERM.; DA. 1975; VOL. 8; NO 3-4; PP. 181-188; BIBL. 1P.1/2Article

Distribution and subtype determination of β-receptors in the spinal cord of the adult ratSCHRADER, E; GROBECKER, H.Cellular and molecular neurobiology. 1989, Vol 9, Num 4, pp 451-468, issn 0272-4340Article

COMPARATIVE DETERMINATION OF CEFOTAXIME AND DESACETYL CEFOTAXIME IN SERUM AND BILE BY BIOASSAY AND HIGH-PERFORMANCE LIQUID CHROMATOGRAPHYKEES F; STREHL E; SEEGER K et al.1981; ARZNEIM.-FORSCH.; ISSN 0004-4172; DEU; DA. 1981; VOL. 31; NO 2; PP. 362-365; ABS. GER; BIBL. 10 REF.Article

DOPAMINE-BETA -HYDROXYLASE ACTIVITY AND CATECHOLAMINE CONCENTRATIONS IN PLASMA: EXPERIMENTAL AND ESSENTIAL HYPERTENSION.GROBECKER H; SAAVEDRA JM; MCCARTY R et al.1977; POSTGRAD. MED. J., SUPPL.; G.B.; DA. 1977; VOL. 53; NO 3; PP. 43-48; BIBL. 26 REF.Conference Paper

SPEZIFISCHE UND UNSPEZIFISCHE WIRKUNGEN VON BETA -SYMPATHOLYTIKA AM MENSCHEN. = EFFETS SPECIFIQUES ET NON SPECIFIQUES DES BETA -SYMPATHOLYTIQUES CHEZ L'HOMMEGROBECKER H; PLANZ G; WIETHOLD G et al.1976; KLIN. WSCHR.; DTSCH.; DA. 1976; VOL. 54; NO 16; PP. 783-788; ABS. ANGL.; BIBL. 18 REF.Article

EFFECT OF PROLONGED TREATMENT WITH ADRENERGIC NEURON BLOCKING DRUGS ON SYMPATHOADRENAL REACTIVITY IN RATS.GROBECKER H; ROIZEN MF; JACOBOWITZ DM et al.1977; EUROP. J. PHARMACOL.; NETHERL.; DA. 1977; VOL. 46; NO 2; PP. 125-133; BIBL. 1 P. 1/2Article

HUMAN BLOOD PLATELETS AS CELLULAR MODELS FOR INVESTIGATION OF MEMBRANE ACTIVE DRUGS: BETA-ADRENERGIC BLOCKING AGENTS = THROMBOCYTES DE SANG HUMAIN COMME MODELE CELLULAIRE POUR L'ETUDE DES MEDICAMENTS ACTIFS SUR LES MEMBRANES: AGENTS BLOQUANTS BETA -ADRENERGIQUESLEMMER B; WIETHOLD G; HELLENBRECHT D et al.1972; ARCH. (NAUNYM-SCHMIEDEBERG'S) PHARMACOL.; GERM.; DA. 1972; VOL. 275; NO 3; PP. 299-313; BIBL. 22REF.Serial Issue

INHIBITION BY ANTIARRHYTHMIC AND BETA -SYMPATHOLYTIC DRUGS OF SEROTONIN UPTAKE BY HUMAN PLATELETS: EXPERIMENTS IN VITRO AND IN VIVO = INHIBITION DE LA FIXATION DE SEROTONINE PAR LES THROMBOCYTES HUMAINS, DUE AUX ANTIARYTHMIQUES ET AUX MEDICAMENTS BETA -BLOQUANTS ADRENERGIQUES: ETUDE IN VITRO ET IN VIVOGROBECKER H; LEMMER B; HELLENBRECHT D et al.1973; EUROP. J. CLIN. PHARMACOL.; GERM.; DA. 1973; VOL. 5; NO 3; PP. 145-150; BIBL. 1P.Serial Issue

MEASUREMENT OF HYDROPHOBICITY, SURFACE ACTIVITY, LOCAL ANAESTHESIA, AND MYOCARDIAL CONDUCTION VELOCITY AS QUANTITATIVE PARAMETERS OF THE NON-SPECIFIC MEMBRANE AFFINITY OF NINE BETA -ADRENERGIC BLOCKING = MESURE DE L'HYDROPHOBICITE, DE L'ACTIVITE DE SURFACE, DE L'ANESTHESIE LOCALE ET DE LA VITESSE DE CONDUCTION CARDIAQUE COMME PARAMETRES QUANTITATIFS DE L'AFFINITE DE MEMBRANE NON SPECIFIQUE DE 9 BLOQUANTS BETA -ADRENERGIQUESHELLENBRECHT D; LEMMER B; WIETHOLD G et al.1973; ARCH. (NAUNYN-SCHMIEDEBERG'S) PHARMAKOL.; GERM.; DA. 1973; VOL. 277; NO 2; PP. 211-226; BIBL. 1 P. 1/2Serial Issue

PHYSIOLOGY AND PATHOLOGY OF VASCULAR RESPONSE = PHYSIOLOGIE ET PATHOLOGIE DE LA REPONSE VASCULAIREDISTLER A; GROBECKER H; KREYE VAW et al.1973; ARZNEIMITTEL-FORSCH.; DTSCH.; DA. 1973; VOL. 23; NO 1; PP. 18-30Serial Issue

Bioavailability of cefpodoxime proxetil with co-administered acetylcysteineKEES, F; WELLENHOFER, M; BRÖHL, K et al.Arzneimittel-Forschung. 1996, Vol 46, Num 4, pp 435-438, issn 0004-4172Article

Strukturelle Charakterisierung eines unbekannten Metaboliten von Ciprofloxacin = Structural characterization of an unknown metabolite of ciprofloxacinKEES, F; RAASCH, W; GROBECKER, H et al.Arzneimittel-Forschung. 1992, Vol 42, Num 4, pp 570-575, issn 0004-4172Article

High-performance liquid chromatographic assay for cefotiam and d3-cefotiam in human serumKEES, F; RAASCH, W; STEGER, M et al.Journal of chromatography. Biomedical applications. 1990, Vol 525, Num 2, pp 484-489, issn 0378-4347Article

Circulating and tissue catecholamines in rats with chronic neurogenic hypertensionDOMINIAK, P; KEES, F; GROBECKER, H et al.Basic research in cardiology. 1986, Vol 81, Num 1, pp 20-28, issn 0300-8428Article

High-performance liquid chromatographic analysis of cefotetan epimers in human plasma and urineKEES, F; GROBECKER, H; NABER, K. G et al.Journal of chromatography. 1984, Vol 305, Num 2, pp 363-371, issn 0021-9673Article

EXERCISE INDUCED CHANGES OF CATECHOLAMINES AND POTASSIUM IN PLASMA OF DOGS AFTER TREATMENT WITH PROPRANOLOLSTAIB AH; APPEL E; STAREY F et al.1980; ARZNEIM.-FORSCH.; ISSN 0004-4172; DEU; DA. 1980; NO 9; PP. 1514-1517; ABS. GER; BIBL. 18 REF.Article

  • Page / 3